nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentobarbital—CYP2A6—Pilocarpine—glaucoma	0.246	0.423	CbGbCtD
Pentobarbital—CYP2C19—Methazolamide—glaucoma	0.0687	0.118	CbGbCtD
Pentobarbital—CYP2C19—Timolol—glaucoma	0.0585	0.1	CbGbCtD
Pentobarbital—CYP3A4—Pilocarpine—glaucoma	0.0492	0.0845	CbGbCtD
Pentobarbital—CYP3A4—Brinzolamide—glaucoma	0.0386	0.0663	CbGbCtD
Pentobarbital—CYP3A4—Dorzolamide—glaucoma	0.0373	0.064	CbGbCtD
Pentobarbital—CYP3A4—Methazolamide—glaucoma	0.0332	0.0571	CbGbCtD
Pentobarbital—CYP3A4—Acetazolamide—glaucoma	0.0266	0.0456	CbGbCtD
Pentobarbital—CYP3A4—Clonidine—glaucoma	0.024	0.0413	CbGbCtD
Pentobarbital—Dermatitis exfoliative—Dorzolamide—glaucoma	0.00264	0.00666	CcSEcCtD
Pentobarbital—Respiratory failure—Clonidine—glaucoma	0.00264	0.00665	CcSEcCtD
Pentobarbital—Ataxia—Acetazolamide—glaucoma	0.00256	0.00645	CcSEcCtD
Pentobarbital—Tension—Diclofenamide—glaucoma	0.00252	0.00636	CcSEcCtD
Pentobarbital—Nightmare—Clonidine—glaucoma	0.0025	0.00631	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Pilocarpine—glaucoma	0.00249	0.00629	CcSEcCtD
Pentobarbital—Nervousness—Diclofenamide—glaucoma	0.00249	0.00629	CcSEcCtD
Pentobarbital—Anxiety—Metipranolol—glaucoma	0.00239	0.00603	CcSEcCtD
Pentobarbital—Syncope—Carteolol—glaucoma	0.00234	0.00591	CcSEcCtD
Pentobarbital—Respiratory failure—Betaxolol—glaucoma	0.0023	0.00579	CcSEcCtD
Pentobarbital—Loss of consciousness—Carteolol—glaucoma	0.0023	0.00579	CcSEcCtD
Pentobarbital—Syncope—Carbachol—glaucoma	0.00225	0.00567	CcSEcCtD
Pentobarbital—Syncope—Levobunolol—glaucoma	0.00221	0.00558	CcSEcCtD
Pentobarbital—Loss of consciousness—Carbachol—glaucoma	0.0022	0.00556	CcSEcCtD
Pentobarbital—Depressed level of consciousness—Betaxolol—glaucoma	0.00218	0.00549	CcSEcCtD
Pentobarbital—Nightmare—Betaxolol—glaucoma	0.00218	0.00549	CcSEcCtD
Pentobarbital—Loss of consciousness—Levobunolol—glaucoma	0.00217	0.00547	CcSEcCtD
Pentobarbital—Bradycardia—Apraclonidine—glaucoma	0.00214	0.0054	CcSEcCtD
Pentobarbital—Confusional state—Diclofenamide—glaucoma	0.00211	0.00533	CcSEcCtD
Pentobarbital—Shock—Carteolol—glaucoma	0.0021	0.00529	CcSEcCtD
Pentobarbital—Somnolence—Metipranolol—glaucoma	0.00205	0.00516	CcSEcCtD
Pentobarbital—Confusional state—Levobunolol—glaucoma	0.00203	0.00512	CcSEcCtD
Pentobarbital—Shock—Carbachol—glaucoma	0.00201	0.00508	CcSEcCtD
Pentobarbital—Hypotension—Carteolol—glaucoma	0.00199	0.00502	CcSEcCtD
Pentobarbital—Shock—Levobunolol—glaucoma	0.00198	0.005	CcSEcCtD
Pentobarbital—Confusional state—Methazolamide—glaucoma	0.00195	0.00491	CcSEcCtD
Pentobarbital—Hypotension—Carbachol—glaucoma	0.00191	0.00482	CcSEcCtD
Pentobarbital—Hypotension—Levobunolol—glaucoma	0.00188	0.00475	CcSEcCtD
Pentobarbital—Respiratory failure—Timolol—glaucoma	0.00188	0.00473	CcSEcCtD
Pentobarbital—Somnolence—Diclofenamide—glaucoma	0.00186	0.0047	CcSEcCtD
Pentobarbital—Bradycardia—Brimonidine—glaucoma	0.00184	0.00463	CcSEcCtD
Pentobarbital—Tension—Apraclonidine—glaucoma	0.0018	0.00453	CcSEcCtD
Pentobarbital—Constipation—Diclofenamide—glaucoma	0.00179	0.00452	CcSEcCtD
Pentobarbital—Nightmare—Timolol—glaucoma	0.00178	0.00449	CcSEcCtD
Pentobarbital—Nervousness—Apraclonidine—glaucoma	0.00178	0.00448	CcSEcCtD
Pentobarbital—Bradycardia—Dorzolamide—glaucoma	0.00175	0.00443	CcSEcCtD
Pentobarbital—Bradycardia—Travoprost—glaucoma	0.00175	0.00441	CcSEcCtD
Pentobarbital—Tension—Bimatoprost—glaucoma	0.00174	0.00439	CcSEcCtD
Pentobarbital—Feeling abnormal—Diclofenamide—glaucoma	0.00173	0.00436	CcSEcCtD
Pentobarbital—Bradycardia—Brinzolamide—glaucoma	0.00172	0.00435	CcSEcCtD
Pentobarbital—Nervousness—Bimatoprost—glaucoma	0.00172	0.00435	CcSEcCtD
Pentobarbital—Somnolence—Methazolamide—glaucoma	0.00172	0.00433	CcSEcCtD
Pentobarbital—Hallucination—Dorzolamide—glaucoma	0.00171	0.00433	CcSEcCtD
Pentobarbital—Hypersensitivity—Metipranolol—glaucoma	0.00169	0.00428	CcSEcCtD
Pentobarbital—Feeling abnormal—Levobunolol—glaucoma	0.00166	0.00419	CcSEcCtD
Pentobarbital—Bradycardia—Pilocarpine—glaucoma	0.00166	0.00418	CcSEcCtD
Pentobarbital—Body temperature increased—Diclofenamide—glaucoma	0.00166	0.00418	CcSEcCtD
Pentobarbital—Syncope—Apraclonidine—glaucoma	0.00164	0.00414	CcSEcCtD
Pentobarbital—Body temperature increased—Carbachol—glaucoma	0.00162	0.00408	CcSEcCtD
Pentobarbital—Feeling abnormal—Methazolamide—glaucoma	0.00159	0.00401	CcSEcCtD
Pentobarbital—Hypersensitivity—Carteolol—glaucoma	0.00157	0.00396	CcSEcCtD
Pentobarbital—Ataxia—Betaxolol—glaucoma	0.00154	0.00388	CcSEcCtD
Pentobarbital—Body temperature increased—Methazolamide—glaucoma	0.00153	0.00385	CcSEcCtD
Pentobarbital—Dizziness—Metipranolol—glaucoma	0.00152	0.00384	CcSEcCtD
Pentobarbital—Anxiety—Bimatoprost—glaucoma	0.0015	0.0038	CcSEcCtD
Pentobarbital—Agitation—Acetazolamide—glaucoma	0.0015	0.00379	CcSEcCtD
Pentobarbital—Hypersensitivity—Levobunolol—glaucoma	0.00148	0.00374	CcSEcCtD
Pentobarbital—Tension—Dorzolamide—glaucoma	0.00147	0.00371	CcSEcCtD
Pentobarbital—Nervousness—Dorzolamide—glaucoma	0.00146	0.00368	CcSEcCtD
Pentobarbital—Rash—Metipranolol—glaucoma	0.00145	0.00366	CcSEcCtD
Pentobarbital—Dermatitis—Metipranolol—glaucoma	0.00145	0.00366	CcSEcCtD
Pentobarbital—Tension—Brinzolamide—glaucoma	0.00145	0.00365	CcSEcCtD
Pentobarbital—Headache—Metipranolol—glaucoma	0.00144	0.00364	CcSEcCtD
Pentobarbital—Nervousness—Brinzolamide—glaucoma	0.00143	0.00361	CcSEcCtD
Pentobarbital—Dermatitis exfoliative—Timolol—glaucoma	0.00142	0.00357	CcSEcCtD
Pentobarbital—Dizziness—Carteolol—glaucoma	0.00141	0.00356	CcSEcCtD
Pentobarbital—Syncope—Brimonidine—glaucoma	0.00141	0.00355	CcSEcCtD
Pentobarbital—Tension—Pilocarpine—glaucoma	0.00139	0.00351	CcSEcCtD
Pentobarbital—Dizziness—Diclofenamide—glaucoma	0.00139	0.0035	CcSEcCtD
Pentobarbital—Loss of consciousness—Brimonidine—glaucoma	0.00138	0.00348	CcSEcCtD
Pentobarbital—Nervousness—Pilocarpine—glaucoma	0.00138	0.00347	CcSEcCtD
Pentobarbital—Angioedema—Dorzolamide—glaucoma	0.00137	0.00346	CcSEcCtD
Pentobarbital—Nausea—Metipranolol—glaucoma	0.00137	0.00345	CcSEcCtD
Pentobarbital—Agitation—Brinzolamide—glaucoma	0.00136	0.00342	CcSEcCtD
Pentobarbital—Dizziness—Carbachol—glaucoma	0.00135	0.00341	CcSEcCtD
Pentobarbital—Confusional state—Acetazolamide—glaucoma	0.00135	0.0034	CcSEcCtD
Pentobarbital—Syncope—Dorzolamide—glaucoma	0.00135	0.00339	CcSEcCtD
Pentobarbital—Headache—Carteolol—glaucoma	0.00134	0.00337	CcSEcCtD
Pentobarbital—Anxiety—Brimonidine—glaucoma	0.00133	0.00336	CcSEcCtD
Pentobarbital—Vomiting—Diclofenamide—glaucoma	0.00133	0.00336	CcSEcCtD
Pentobarbital—Dizziness—Levobunolol—glaucoma	0.00133	0.00336	CcSEcCtD
Pentobarbital—Somnolence—Apraclonidine—glaucoma	0.00133	0.00335	CcSEcCtD
Pentobarbital—Bradycardia—Clonidine—glaucoma	0.00132	0.00334	CcSEcCtD
Pentobarbital—Rash—Diclofenamide—glaucoma	0.00132	0.00333	CcSEcCtD
Pentobarbital—Loss of consciousness—Dorzolamide—glaucoma	0.00132	0.00333	CcSEcCtD
Pentobarbital—Shock—Acetazolamide—glaucoma	0.00131	0.00332	CcSEcCtD
Pentobarbital—Headache—Diclofenamide—glaucoma	0.00131	0.00331	CcSEcCtD
Pentobarbital—Agitation—Pilocarpine—glaucoma	0.0013	0.00329	CcSEcCtD
Pentobarbital—Vomiting—Carbachol—glaucoma	0.0013	0.00328	CcSEcCtD
Pentobarbital—Hallucination—Clonidine—glaucoma	0.00129	0.00326	CcSEcCtD
Pentobarbital—Rash—Carbachol—glaucoma	0.00129	0.00325	CcSEcCtD
Pentobarbital—Dermatitis—Carbachol—glaucoma	0.00129	0.00325	CcSEcCtD
Pentobarbital—Somnolence—Bimatoprost—glaucoma	0.00129	0.00325	CcSEcCtD
Pentobarbital—Headache—Carbachol—glaucoma	0.00128	0.00323	CcSEcCtD
Pentobarbital—Constipation—Apraclonidine—glaucoma	0.00128	0.00322	CcSEcCtD
Pentobarbital—Anxiety—Dorzolamide—glaucoma	0.00127	0.00321	CcSEcCtD
Pentobarbital—Syncope—Pilocarpine—glaucoma	0.00127	0.00321	CcSEcCtD
Pentobarbital—Anxiety—Travoprost—glaucoma	0.00127	0.0032	CcSEcCtD
Pentobarbital—Nausea—Carteolol—glaucoma	0.00127	0.00319	CcSEcCtD
Pentobarbital—Headache—Levobunolol—glaucoma	0.00126	0.00318	CcSEcCtD
Pentobarbital—Shock—Brimonidine—glaucoma	0.00126	0.00318	CcSEcCtD
Pentobarbital—Loss of consciousness—Pilocarpine—glaucoma	0.00125	0.00314	CcSEcCtD
Pentobarbital—Nausea—Diclofenamide—glaucoma	0.00124	0.00314	CcSEcCtD
Pentobarbital—Dizziness—Latanoprost—glaucoma	0.00123	0.00312	CcSEcCtD
Pentobarbital—Confusional state—Dorzolamide—glaucoma	0.00123	0.00311	CcSEcCtD
Pentobarbital—Feeling abnormal—Apraclonidine—glaucoma	0.00123	0.0031	CcSEcCtD
Pentobarbital—Vomiting—Methazolamide—glaucoma	0.00123	0.00309	CcSEcCtD
Pentobarbital—Rash—Methazolamide—glaucoma	0.00122	0.00307	CcSEcCtD
Pentobarbital—Dermatitis—Methazolamide—glaucoma	0.00122	0.00307	CcSEcCtD
Pentobarbital—Nausea—Carbachol—glaucoma	0.00121	0.00306	CcSEcCtD
Pentobarbital—Headache—Methazolamide—glaucoma	0.00121	0.00305	CcSEcCtD
Pentobarbital—Shock—Dorzolamide—glaucoma	0.0012	0.00304	CcSEcCtD
Pentobarbital—Anxiety—Pilocarpine—glaucoma	0.0012	0.00303	CcSEcCtD
Pentobarbital—Hypotension—Brimonidine—glaucoma	0.0012	0.00302	CcSEcCtD
Pentobarbital—Nausea—Levobunolol—glaucoma	0.0012	0.00302	CcSEcCtD
Pentobarbital—Somnolence—Acetazolamide—glaucoma	0.00119	0.003	CcSEcCtD
Pentobarbital—Rash—Latanoprost—glaucoma	0.00118	0.00297	CcSEcCtD
Pentobarbital—Dermatitis—Latanoprost—glaucoma	0.00118	0.00297	CcSEcCtD
Pentobarbital—Headache—Latanoprost—glaucoma	0.00117	0.00295	CcSEcCtD
Pentobarbital—Confusional state—Pilocarpine—glaucoma	0.00117	0.00294	CcSEcCtD
Pentobarbital—Bradycardia—Betaxolol—glaucoma	0.00115	0.00291	CcSEcCtD
Pentobarbital—Nausea—Methazolamide—glaucoma	0.00115	0.00289	CcSEcCtD
Pentobarbital—Hypotension—Dorzolamide—glaucoma	0.00114	0.00289	CcSEcCtD
Pentobarbital—Somnolence—Brimonidine—glaucoma	0.00114	0.00287	CcSEcCtD
Pentobarbital—Hypotension—Travoprost—glaucoma	0.00114	0.00287	CcSEcCtD
Pentobarbital—Shock—Pilocarpine—glaucoma	0.00114	0.00287	CcSEcCtD
Pentobarbital—Hallucination—Betaxolol—glaucoma	0.00113	0.00284	CcSEcCtD
Pentobarbital—Hypotension—Brinzolamide—glaucoma	0.00112	0.00284	CcSEcCtD
Pentobarbital—Tension—Clonidine—glaucoma	0.00111	0.0028	CcSEcCtD
Pentobarbital—Feeling abnormal—Acetazolamide—glaucoma	0.0011	0.00278	CcSEcCtD
Pentobarbital—Hypersensitivity—Apraclonidine—glaucoma	0.0011	0.00278	CcSEcCtD
Pentobarbital—Nervousness—Clonidine—glaucoma	0.0011	0.00277	CcSEcCtD
Pentobarbital—Somnolence—Dorzolamide—glaucoma	0.00109	0.00275	CcSEcCtD
Pentobarbital—Hypotension—Pilocarpine—glaucoma	0.00108	0.00273	CcSEcCtD
Pentobarbital—Somnolence—Brinzolamide—glaucoma	0.00107	0.0027	CcSEcCtD
Pentobarbital—Body temperature increased—Acetazolamide—glaucoma	0.00106	0.00266	CcSEcCtD
Pentobarbital—Constipation—Travoprost—glaucoma	0.00104	0.00263	CcSEcCtD
Pentobarbital—Agitation—Clonidine—glaucoma	0.00104	0.00262	CcSEcCtD
Pentobarbital—Angioedema—Clonidine—glaucoma	0.00103	0.00261	CcSEcCtD
Pentobarbital—Somnolence—Pilocarpine—glaucoma	0.00103	0.00259	CcSEcCtD
Pentobarbital—Syncope—Clonidine—glaucoma	0.00101	0.00256	CcSEcCtD
Pentobarbital—Feeling abnormal—Dorzolamide—glaucoma	0.00101	0.00255	CcSEcCtD
Pentobarbital—Feeling abnormal—Travoprost—glaucoma	0.001	0.00253	CcSEcCtD
Pentobarbital—Loss of consciousness—Clonidine—glaucoma	0.000995	0.00251	CcSEcCtD
Pentobarbital—Feeling abnormal—Brinzolamide—glaucoma	0.000992	0.0025	CcSEcCtD
Pentobarbital—Constipation—Pilocarpine—glaucoma	0.000989	0.0025	CcSEcCtD
Pentobarbital—Dizziness—Apraclonidine—glaucoma	0.000987	0.00249	CcSEcCtD
Pentobarbital—Body temperature increased—Dorzolamide—glaucoma	0.000968	0.00244	CcSEcCtD
Pentobarbital—Tension—Betaxolol—glaucoma	0.000967	0.00244	CcSEcCtD
Pentobarbital—Anxiety—Clonidine—glaucoma	0.00096	0.00242	CcSEcCtD
Pentobarbital—Dizziness—Bimatoprost—glaucoma	0.000957	0.00242	CcSEcCtD
Pentobarbital—Nervousness—Betaxolol—glaucoma	0.000957	0.00241	CcSEcCtD
Pentobarbital—Feeling abnormal—Pilocarpine—glaucoma	0.000953	0.0024	CcSEcCtD
Pentobarbital—Vomiting—Apraclonidine—glaucoma	0.000949	0.0024	CcSEcCtD
Pentobarbital—Hypersensitivity—Brimonidine—glaucoma	0.000944	0.00238	CcSEcCtD
Pentobarbital—Bradycardia—Timolol—glaucoma	0.000941	0.00238	CcSEcCtD
Pentobarbital—Dermatitis—Apraclonidine—glaucoma	0.000941	0.00237	CcSEcCtD
Pentobarbital—Headache—Apraclonidine—glaucoma	0.000935	0.00236	CcSEcCtD
Pentobarbital—Confusional state—Clonidine—glaucoma	0.000931	0.00235	CcSEcCtD
Pentobarbital—Hallucination—Timolol—glaucoma	0.00092	0.00232	CcSEcCtD
Pentobarbital—Body temperature increased—Pilocarpine—glaucoma	0.000914	0.00231	CcSEcCtD
Pentobarbital—Rash—Bimatoprost—glaucoma	0.000913	0.0023	CcSEcCtD
Pentobarbital—Dermatitis—Bimatoprost—glaucoma	0.000912	0.0023	CcSEcCtD
Pentobarbital—Shock—Clonidine—glaucoma	0.000909	0.00229	CcSEcCtD
Pentobarbital—Headache—Bimatoprost—glaucoma	0.000907	0.00229	CcSEcCtD
Pentobarbital—Hypersensitivity—Dorzolamide—glaucoma	0.000902	0.00228	CcSEcCtD
Pentobarbital—Hypersensitivity—Travoprost—glaucoma	0.000898	0.00227	CcSEcCtD
Pentobarbital—Nausea—Apraclonidine—glaucoma	0.000887	0.00224	CcSEcCtD
Pentobarbital—Hypersensitivity—Brinzolamide—glaucoma	0.000887	0.00224	CcSEcCtD
Pentobarbital—Syncope—Betaxolol—glaucoma	0.000884	0.00223	CcSEcCtD
Pentobarbital—Dizziness—Acetazolamide—glaucoma	0.000883	0.00223	CcSEcCtD
Pentobarbital—Loss of consciousness—Betaxolol—glaucoma	0.000866	0.00219	CcSEcCtD
Pentobarbital—Hypotension—Clonidine—glaucoma	0.000863	0.00218	CcSEcCtD
Pentobarbital—Nausea—Bimatoprost—glaucoma	0.00086	0.00217	CcSEcCtD
Pentobarbital—Hypersensitivity—Pilocarpine—glaucoma	0.000852	0.00215	CcSEcCtD
Pentobarbital—Vomiting—Acetazolamide—glaucoma	0.000849	0.00214	CcSEcCtD
Pentobarbital—Dizziness—Brimonidine—glaucoma	0.000848	0.00214	CcSEcCtD
Pentobarbital—Headache—Acetazolamide—glaucoma	0.000837	0.00211	CcSEcCtD
Pentobarbital—Anxiety—Betaxolol—glaucoma	0.000836	0.00211	CcSEcCtD
Pentobarbital—Somnolence—Clonidine—glaucoma	0.000821	0.00207	CcSEcCtD
Pentobarbital—Confusional state—Betaxolol—glaucoma	0.000811	0.00205	CcSEcCtD
Pentobarbital—Dizziness—Dorzolamide—glaucoma	0.000809	0.00204	CcSEcCtD
Pentobarbital—Rash—Brimonidine—glaucoma	0.000808	0.00204	CcSEcCtD
Pentobarbital—Dermatitis—Brimonidine—glaucoma	0.000807	0.00204	CcSEcCtD
Pentobarbital—Dizziness—Travoprost—glaucoma	0.000806	0.00203	CcSEcCtD
Pentobarbital—Headache—Brimonidine—glaucoma	0.000803	0.00203	CcSEcCtD
Pentobarbital—Dizziness—Brinzolamide—glaucoma	0.000796	0.00201	CcSEcCtD
Pentobarbital—Nausea—Acetazolamide—glaucoma	0.000793	0.002	CcSEcCtD
Pentobarbital—Shock—Betaxolol—glaucoma	0.000791	0.002	CcSEcCtD
Pentobarbital—Tension—Timolol—glaucoma	0.00079	0.00199	CcSEcCtD
Pentobarbital—Constipation—Clonidine—glaucoma	0.00079	0.00199	CcSEcCtD
Pentobarbital—Nervousness—Timolol—glaucoma	0.000782	0.00197	CcSEcCtD
Pentobarbital—Vomiting—Dorzolamide—glaucoma	0.000778	0.00196	CcSEcCtD
Pentobarbital—Rash—Dorzolamide—glaucoma	0.000772	0.00195	CcSEcCtD
Pentobarbital—Dermatitis—Dorzolamide—glaucoma	0.000771	0.00195	CcSEcCtD
Pentobarbital—Rash—Travoprost—glaucoma	0.000769	0.00194	CcSEcCtD
Pentobarbital—Dermatitis—Travoprost—glaucoma	0.000768	0.00194	CcSEcCtD
Pentobarbital—Headache—Dorzolamide—glaucoma	0.000767	0.00193	CcSEcCtD
Pentobarbital—Vomiting—Brinzolamide—glaucoma	0.000765	0.00193	CcSEcCtD
Pentobarbital—Dizziness—Pilocarpine—glaucoma	0.000765	0.00193	CcSEcCtD
Pentobarbital—Headache—Travoprost—glaucoma	0.000764	0.00193	CcSEcCtD
Pentobarbital—Nausea—Brimonidine—glaucoma	0.000761	0.00192	CcSEcCtD
Pentobarbital—Feeling abnormal—Clonidine—glaucoma	0.000761	0.00192	CcSEcCtD
Pentobarbital—Rash—Brinzolamide—glaucoma	0.000759	0.00191	CcSEcCtD
Pentobarbital—Dermatitis—Brinzolamide—glaucoma	0.000758	0.00191	CcSEcCtD
Pentobarbital—Headache—Brinzolamide—glaucoma	0.000754	0.0019	CcSEcCtD
Pentobarbital—Hypotension—Betaxolol—glaucoma	0.000751	0.0019	CcSEcCtD
Pentobarbital—Angioedema—Timolol—glaucoma	0.000736	0.00186	CcSEcCtD
Pentobarbital—Vomiting—Pilocarpine—glaucoma	0.000735	0.00186	CcSEcCtD
Pentobarbital—Body temperature increased—Clonidine—glaucoma	0.00073	0.00184	CcSEcCtD
Pentobarbital—Rash—Pilocarpine—glaucoma	0.000729	0.00184	CcSEcCtD
Pentobarbital—Dermatitis—Pilocarpine—glaucoma	0.000729	0.00184	CcSEcCtD
Pentobarbital—Nausea—Dorzolamide—glaucoma	0.000727	0.00183	CcSEcCtD
Pentobarbital—Headache—Pilocarpine—glaucoma	0.000725	0.00183	CcSEcCtD
Pentobarbital—Nausea—Travoprost—glaucoma	0.000724	0.00183	CcSEcCtD
Pentobarbital—Syncope—Timolol—glaucoma	0.000722	0.00182	CcSEcCtD
Pentobarbital—Nausea—Brinzolamide—glaucoma	0.000715	0.0018	CcSEcCtD
Pentobarbital—Loss of consciousness—Timolol—glaucoma	0.000708	0.00179	CcSEcCtD
Pentobarbital—Constipation—Betaxolol—glaucoma	0.000688	0.00174	CcSEcCtD
Pentobarbital—Nausea—Pilocarpine—glaucoma	0.000687	0.00173	CcSEcCtD
Pentobarbital—Anxiety—Timolol—glaucoma	0.000683	0.00172	CcSEcCtD
Pentobarbital—Hypersensitivity—Clonidine—glaucoma	0.000681	0.00172	CcSEcCtD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000666	0.0311	CbGpPWpGaD
Pentobarbital—Feeling abnormal—Betaxolol—glaucoma	0.000663	0.00167	CcSEcCtD
Pentobarbital—Confusional state—Timolol—glaucoma	0.000662	0.00167	CcSEcCtD
Pentobarbital—Shock—Timolol—glaucoma	0.000646	0.00163	CcSEcCtD
Pentobarbital—Body temperature increased—Betaxolol—glaucoma	0.000636	0.0016	CcSEcCtD
Pentobarbital—Hypotension—Timolol—glaucoma	0.000614	0.00155	CcSEcCtD
Pentobarbital—Dizziness—Clonidine—glaucoma	0.000611	0.00154	CcSEcCtD
Pentobarbital—Hypersensitivity—Betaxolol—glaucoma	0.000592	0.00149	CcSEcCtD
Pentobarbital—Vomiting—Clonidine—glaucoma	0.000587	0.00148	CcSEcCtD
Pentobarbital—Somnolence—Timolol—glaucoma	0.000584	0.00147	CcSEcCtD
Pentobarbital—Rash—Clonidine—glaucoma	0.000582	0.00147	CcSEcCtD
Pentobarbital—Dermatitis—Clonidine—glaucoma	0.000582	0.00147	CcSEcCtD
Pentobarbital—Headache—Clonidine—glaucoma	0.000579	0.00146	CcSEcCtD
Pentobarbital—Nausea—Clonidine—glaucoma	0.000549	0.00138	CcSEcCtD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000543	0.0254	CbGpPWpGaD
Pentobarbital—Feeling abnormal—Timolol—glaucoma	0.000541	0.00137	CcSEcCtD
Pentobarbital—Dizziness—Betaxolol—glaucoma	0.000532	0.00134	CcSEcCtD
Pentobarbital—Body temperature increased—Timolol—glaucoma	0.000519	0.00131	CcSEcCtD
Pentobarbital—Vomiting—Betaxolol—glaucoma	0.000511	0.00129	CcSEcCtD
Pentobarbital—Rash—Betaxolol—glaucoma	0.000507	0.00128	CcSEcCtD
Pentobarbital—Dermatitis—Betaxolol—glaucoma	0.000507	0.00128	CcSEcCtD
Pentobarbital—Headache—Betaxolol—glaucoma	0.000504	0.00127	CcSEcCtD
Pentobarbital—Hypersensitivity—Timolol—glaucoma	0.000484	0.00122	CcSEcCtD
Pentobarbital—Nausea—Betaxolol—glaucoma	0.000478	0.00121	CcSEcCtD
Pentobarbital—Dizziness—Timolol—glaucoma	0.000434	0.0011	CcSEcCtD
Pentobarbital—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000425	0.0199	CbGpPWpGaD
Pentobarbital—Vomiting—Timolol—glaucoma	0.000418	0.00105	CcSEcCtD
Pentobarbital—Rash—Timolol—glaucoma	0.000414	0.00105	CcSEcCtD
Pentobarbital—Dermatitis—Timolol—glaucoma	0.000414	0.00104	CcSEcCtD
Pentobarbital—Headache—Timolol—glaucoma	0.000412	0.00104	CcSEcCtD
Pentobarbital—Nausea—Timolol—glaucoma	0.00039	0.000985	CcSEcCtD
Pentobarbital—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000387	0.0181	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—LMX1B—glaucoma	0.000336	0.0157	CbGpPWpGaD
Pentobarbital—CYP2A6—Tamoxifen metabolism—CYP1B1—glaucoma	0.000322	0.015	CbGpPWpGaD
Pentobarbital—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—glaucoma	0.000272	0.0127	CbGpPWpGaD
Pentobarbital—GRIK2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.00027	0.0126	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—NCK2—glaucoma	0.000252	0.0117	CbGpPWpGaD
Pentobarbital—CHRNA7—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000246	0.0115	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000239	0.0111	CbGpPWpGaD
Pentobarbital—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000233	0.0109	CbGpPWpGaD
Pentobarbital—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000227	0.0106	CbGpPWpGaD
Pentobarbital—GRIK2—Neuronal System—SLC6A13—glaucoma	0.000207	0.00968	CbGpPWpGaD
Pentobarbital—GRIA2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000207	0.00966	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000201	0.00937	CbGpPWpGaD
Pentobarbital—GRIK2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000198	0.00924	CbGpPWpGaD
Pentobarbital—CYP2C19—Tamoxifen metabolism—CYP1B1—glaucoma	0.000196	0.00917	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.000195	0.00909	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—SLC6A13—glaucoma	0.000188	0.0088	CbGpPWpGaD
Pentobarbital—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—glaucoma	0.00018	0.00843	CbGpPWpGaD
Pentobarbital—CHRNA7—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.00018	0.00841	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—NCK2—glaucoma	0.000176	0.00822	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000172	0.00803	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000171	0.00798	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.00017	0.00793	CbGpPWpGaD
Pentobarbital—CYP2A6—Fluoropyrimidine Activity—MTHFR—glaucoma	0.000159	0.0074	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—SLC6A13—glaucoma	0.000158	0.0074	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—PEX19—glaucoma	0.000157	0.00734	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000155	0.00725	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—PEX19—glaucoma	0.000155	0.00725	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—SLC6A13—glaucoma	0.000154	0.00718	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—NTRK2—glaucoma	0.000153	0.00715	CbGpPWpGaD
Pentobarbital—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000152	0.00709	CbGpPWpGaD
Pentobarbital—GRIK2—Neuronal System—SLC6A1—glaucoma	0.000152	0.00708	CbGpPWpGaD
Pentobarbital—GRIA2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000151	0.00707	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000151	0.00705	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000148	0.00692	CbGpPWpGaD
Pentobarbital—CHRNA4—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000147	0.00686	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000146	0.0068	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000145	0.00676	CbGpPWpGaD
Pentobarbital—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000142	0.00664	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000142	0.00663	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000142	0.00663	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—NTRK2—glaucoma	0.000139	0.0065	CbGpPWpGaD
Pentobarbital—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000139	0.0065	CbGpPWpGaD
Pentobarbital—CHRNA7—Neuronal System—SLC6A1—glaucoma	0.000138	0.00644	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—PEX19—glaucoma	0.000138	0.00644	CbGpPWpGaD
Pentobarbital—CYP2A6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000137	0.00641	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—PEX19—glaucoma	0.000135	0.00632	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—SLC6A13—glaucoma	0.000135	0.00629	CbGpPWpGaD
Pentobarbital—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000134	0.00624	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000133	0.00622	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—PEX19—glaucoma	0.000132	0.00617	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—SLC6A13—glaucoma	0.000132	0.00615	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—NGFR—glaucoma	0.000131	0.00613	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—SLC6A13—glaucoma	0.00013	0.00608	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—PEX19—glaucoma	0.00013	0.00606	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000127	0.00595	CbGpPWpGaD
Pentobarbital—GABRA6—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000126	0.00588	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—NTRK1—glaucoma	0.000125	0.00583	CbGpPWpGaD
Pentobarbital—GABRA4—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000124	0.0058	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—SLC6A13—glaucoma	0.000124	0.0058	CbGpPWpGaD
Pentobarbital—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	0.000123	0.00573	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000122	0.00572	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—HDAC9—glaucoma	0.00012	0.00563	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—SLC6A13—glaucoma	0.000119	0.00556	CbGpPWpGaD
Pentobarbital—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000118	0.00552	CbGpPWpGaD
Pentobarbital—GRIA2—Neuronal System—SLC6A1—glaucoma	0.000116	0.00542	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—SLC6A13—glaucoma	0.000116	0.0054	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—BDNF—glaucoma	0.000114	0.00534	CbGpPWpGaD
Pentobarbital—GABRB2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000114	0.00531	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—SLC6A13—glaucoma	0.000114	0.0053	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000113	0.0053	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—NGF—glaucoma	0.000113	0.00528	CbGpPWpGaD
Pentobarbital—CYP2A6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000113	0.00527	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000113	0.00526	CbGpPWpGaD
Pentobarbital—CHRNA4—Neuronal System—SLC6A1—glaucoma	0.000112	0.00525	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—SLC6A13—glaucoma	0.000112	0.00521	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—SLC6A13—glaucoma	0.000111	0.00518	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—TXN—glaucoma	0.000111	0.00516	CbGpPWpGaD
Pentobarbital—GABRA5—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.00011	0.00516	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—SLC6A13—glaucoma	0.000109	0.00508	CbGpPWpGaD
Pentobarbital—GABRA3—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000108	0.00506	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—NTRK2—glaucoma	0.000107	0.005	CbGpPWpGaD
Pentobarbital—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000107	0.00499	CbGpPWpGaD
Pentobarbital—GABRA2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000107	0.00498	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000106	0.00496	CbGpPWpGaD
Pentobarbital—GABRB3—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000106	0.00494	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000105	0.0049	CbGpPWpGaD
Pentobarbital—GABRG2—Transmission across Chemical Synapses—SLC6A1—glaucoma	0.000104	0.00486	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000104	0.00485	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—NGF—glaucoma	0.000101	0.00474	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1A—glaucoma	9.98e-05	0.00466	CbGpPWpGaD
Pentobarbital—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	9.98e-05	0.00466	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—SLC6A1—glaucoma	9.85e-05	0.0046	CbGpPWpGaD
Pentobarbital—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	9.81e-05	0.00458	CbGpPWpGaD
Pentobarbital—GABRA6—Neuronal System—SLC6A1—glaucoma	9.64e-05	0.0045	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC4A4—glaucoma	9.59e-05	0.00448	CbGpPWpGaD
Pentobarbital—GABRA4—Neuronal System—SLC6A1—glaucoma	9.52e-05	0.00445	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—SLC6A13—glaucoma	9.51e-05	0.00444	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC4A4—glaucoma	9.31e-05	0.00435	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—NGF—glaucoma	9.22e-05	0.00431	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—NGFR—glaucoma	9.19e-05	0.00429	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—NR3C1—glaucoma	9.18e-05	0.00429	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC4A4—glaucoma	9.15e-05	0.00427	CbGpPWpGaD
Pentobarbital—GABRA1—Transmission across Chemical Synapses—SLC6A1—glaucoma	9.09e-05	0.00424	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC4A4—glaucoma	8.99e-05	0.0042	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC4A4—glaucoma	8.93e-05	0.00417	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC4A4—glaucoma	8.77e-05	0.0041	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—NTRK1—glaucoma	8.73e-05	0.00408	CbGpPWpGaD
Pentobarbital—GABRB2—Neuronal System—SLC6A1—glaucoma	8.71e-05	0.00407	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—NTRK2—glaucoma	8.62e-05	0.00403	CbGpPWpGaD
Pentobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.48e-05	0.00396	CbGpPWpGaD
Pentobarbital—GABRA5—Neuronal System—SLC6A1—glaucoma	8.46e-05	0.00395	CbGpPWpGaD
Pentobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.37e-05	0.00391	CbGpPWpGaD
Pentobarbital—GRIA2—BDNF signaling pathway—BAD—glaucoma	8.36e-05	0.00391	CbGpPWpGaD
Pentobarbital—GABRA3—Neuronal System—SLC6A1—glaucoma	8.31e-05	0.00388	CbGpPWpGaD
Pentobarbital—GABRA2—Neuronal System—SLC6A1—glaucoma	8.16e-05	0.00381	CbGpPWpGaD
Pentobarbital—GABRB3—Neuronal System—SLC6A1—glaucoma	8.11e-05	0.00379	CbGpPWpGaD
Pentobarbital—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	8.03e-05	0.00375	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—TGFB2—glaucoma	8.03e-05	0.00375	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—BDNF—glaucoma	7.99e-05	0.00373	CbGpPWpGaD
Pentobarbital—GABRG2—Neuronal System—SLC6A1—glaucoma	7.97e-05	0.00372	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC4A4—glaucoma	7.66e-05	0.00358	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—GSTT1—glaucoma	7.52e-05	0.00351	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—NGF—glaucoma	7.09e-05	0.00331	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.08e-05	0.00331	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.99e-05	0.00327	CbGpPWpGaD
Pentobarbital—GABRA1—Neuronal System—SLC6A1—glaucoma	6.96e-05	0.00325	CbGpPWpGaD
Pentobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.87e-05	0.00321	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—BDNF—glaucoma	6.43e-05	0.00301	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.4e-05	0.00299	CbGpPWpGaD
Pentobarbital—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	6.31e-05	0.00295	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.21e-05	0.0029	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—IL1A—glaucoma	6.18e-05	0.00289	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC6A13—glaucoma	6.1e-05	0.00285	CbGpPWpGaD
Pentobarbital—CYP2A6—Fluoropyrimidine Activity—TP53—glaucoma	6.02e-05	0.00281	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC6A13—glaucoma	6e-05	0.0028	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—CYP1B1—glaucoma	5.99e-05	0.0028	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.96e-05	0.00278	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.85e-05	0.00273	CbGpPWpGaD
Pentobarbital—GABRB3—BDNF signaling pathway—BAD—glaucoma	5.85e-05	0.00273	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—NGF—glaucoma	5.71e-05	0.00267	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—NR3C1—glaucoma	5.68e-05	0.00265	CbGpPWpGaD
Pentobarbital—CYP2A6—NRF2 pathway—GSTM1—glaucoma	5.46e-05	0.00255	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—glaucoma	5.4e-05	0.00252	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CA5A—glaucoma	5.27e-05	0.00246	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NARFL—glaucoma	5.27e-05	0.00246	CbGpPWpGaD
Pentobarbital—GABRA6—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.18e-05	0.00242	CbGpPWpGaD
Pentobarbital—GABRA4—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.12e-05	0.00239	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.11e-05	0.00239	CbGpPWpGaD
Pentobarbital—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.1e-05	0.00238	CbGpPWpGaD
Pentobarbital—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.03e-05	0.00235	CbGpPWpGaD
Pentobarbital—CYP2A6—Biological oxidations—GSTM1—glaucoma	4.79e-05	0.00224	CbGpPWpGaD
Pentobarbital—GABRB2—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.68e-05	0.00219	CbGpPWpGaD
Pentobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—glaucoma	4.63e-05	0.00216	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GSTT1—glaucoma	4.58e-05	0.00214	CbGpPWpGaD
Pentobarbital—GABRA5—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.55e-05	0.00212	CbGpPWpGaD
Pentobarbital—GABRA3—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.47e-05	0.00209	CbGpPWpGaD
Pentobarbital—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	4.42e-05	0.00207	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—glaucoma	4.41e-05	0.00206	CbGpPWpGaD
Pentobarbital—GABRA2—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.39e-05	0.00205	CbGpPWpGaD
Pentobarbital—GABRB3—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.36e-05	0.00204	CbGpPWpGaD
Pentobarbital—GABRG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	4.28e-05	0.002	CbGpPWpGaD
Pentobarbital—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.13e-05	0.00193	CbGpPWpGaD
Pentobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—glaucoma	3.78e-05	0.00176	CbGpPWpGaD
Pentobarbital—GABRA1—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.74e-05	0.00175	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—CYP1B1—glaucoma	3.65e-05	0.00171	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	3.6e-05	0.00168	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.41e-05	0.00159	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CA5A—glaucoma	3.21e-05	0.0015	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NARFL—glaucoma	3.21e-05	0.0015	CbGpPWpGaD
Pentobarbital—CYP2C19—Biological oxidations—GSTM1—glaucoma	2.92e-05	0.00136	CbGpPWpGaD
Pentobarbital—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	2.88e-05	0.00134	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTT1—glaucoma	2.76e-05	0.00129	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—glaucoma	2.73e-05	0.00127	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CA1—glaucoma	2.57e-05	0.0012	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CTSA—glaucoma	2.49e-05	0.00116	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CA2—glaucoma	2.35e-05	0.0011	CbGpPWpGaD
Pentobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—glaucoma	2.34e-05	0.00109	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.2e-05	0.00103	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.17e-05	0.00101	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NARFL—glaucoma	1.93e-05	0.000902	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CA5A—glaucoma	1.93e-05	0.000902	CbGpPWpGaD
Pentobarbital—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.76e-05	0.00082	CbGpPWpGaD
Pentobarbital—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.73e-05	0.000809	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—TXN—glaucoma	1.66e-05	0.000774	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CA1—glaucoma	1.57e-05	0.000733	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CTSA—glaucoma	1.52e-05	0.00071	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CA2—glaucoma	1.43e-05	0.00067	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.4e-05	0.000655	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.4e-05	0.000655	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTT1—glaucoma	1.29e-05	0.0006	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—ABCA1—glaucoma	1.02e-05	0.000478	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CYP1B1—glaucoma	1.02e-05	0.000478	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—TXN—glaucoma	1.01e-05	0.000472	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CA1—glaucoma	9.43e-06	0.000441	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.22e-06	0.000431	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.14e-06	0.000427	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CTSA—glaucoma	9.14e-06	0.000427	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CA2—glaucoma	8.63e-06	0.000403	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—GSTM1—glaucoma	8.19e-06	0.000382	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTT1—glaucoma	7.84e-06	0.000366	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—MTHFR—glaucoma	7.24e-06	0.000338	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—APOE—glaucoma	6.74e-06	0.000315	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—CAV1—glaucoma	6.68e-06	0.000312	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.32e-06	0.000295	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CYP1B1—glaucoma	6.24e-06	0.000292	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—ABCA1—glaucoma	6.24e-06	0.000292	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—TXN—glaucoma	6.08e-06	0.000284	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—NOS3—glaucoma	5.05e-06	0.000236	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—GSTM1—glaucoma	4.99e-06	0.000233	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTT1—glaucoma	4.71e-06	0.00022	CbGpPWpGaD
Pentobarbital—CYP2A6—Metabolism—PTGS2—glaucoma	4.62e-06	0.000216	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—MTHFR—glaucoma	4.41e-06	0.000206	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—APOE—glaucoma	4.11e-06	0.000192	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—CAV1—glaucoma	4.07e-06	0.00019	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—ABCA1—glaucoma	3.76e-06	0.000175	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CYP1B1—glaucoma	3.76e-06	0.000175	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—NOS3—glaucoma	3.08e-06	0.000144	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—GSTM1—glaucoma	3e-06	0.00014	CbGpPWpGaD
Pentobarbital—CYP2C19—Metabolism—PTGS2—glaucoma	2.81e-06	0.000131	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—MTHFR—glaucoma	2.65e-06	0.000124	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—APOE—glaucoma	2.47e-06	0.000115	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—CAV1—glaucoma	2.45e-06	0.000114	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—NOS3—glaucoma	1.85e-06	8.64e-05	CbGpPWpGaD
Pentobarbital—CYP3A4—Metabolism—PTGS2—glaucoma	1.69e-06	7.91e-05	CbGpPWpGaD
